Recent advances in clinical practice challenges and opportunities in the management of obesity

被引:73
作者
Acosta, Andres [1 ]
Abu Dayyeh, Barham K [1 ]
Port, John D [2 ]
Camilleri, Michael [1 ]
机构
[1] Mayo Clin, CENTER, Div Gastroenterol & Hepatol, Coll Med, Rochester, MN USA
[2] Mayo Clin, Div Neuroradiol, Dept Radiol, Coll Med, Rochester, MN USA
基金
美国国家卫生研究院;
关键词
GLUCAGON-LIKE PEPTIDE-1; Y GASTRIC BYPASS; DUODENAL-JEJUNAL BYPASS; RANDOMIZED-CONTROLLED-TRIAL; TYPE-2; DIABETES-MELLITUS; FOOD-INTAKE; BARIATRIC SURGERY; SLEEVE GASTRECTOMY; WEIGHT-LOSS; GLUCOSE-HOMEOSTASIS;
D O I
10.1136/gutjnl-2013-306235
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Despite advances in understanding the roles of adiposity, food intake, GI and adipocyte-related hormones, inflammatory mediators, the gut-brain axis and the hypothalamic nervous system in the pathophysiology of obesity, the effects of different therapeutic interventions on those pathophysiological mechanisms are controversial. There are still no low-cost, safe, effective treatments for obesity and its complications. Currently, bariatric surgical approaches targeting the GI tract are more effective than non-surgical approaches in inducing weight reduction and resolving obesity-related comorbidities. However, current guidelines emphasise non-surgical approaches through lifestyle modification and medications to achieve slow weight loss, which is not usually sustained and may be associated with medication-related side effects. This review analyses current central, peripheral or hormonal targets to treat obesity and addresses challenges and opportunities to develop novel approaches for obesity.
引用
收藏
页码:687 / +
页数:2
相关论文
共 115 条
[1]   Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity [J].
Abu Dayyeh, Barham K. ;
Rajan, Elizabeth ;
Gostout, Christopher J. .
GASTROINTESTINAL ENDOSCOPY, 2013, 78 (03) :530-535
[2]  
Abu Dayyeh Barham K, 2011, Therap Adv Gastroenterol, V4, P433, DOI 10.1177/1756283X11398737
[3]   EFFECTS OF PEPTIDE-YY AND NEUROPEPTIDE-Y ON GASTRIC-EMPTYING IN MAN [J].
ALLEN, JM ;
FITZPATRICK, ML ;
YEATS, JC ;
DARCY, K ;
ADRIAN, TE ;
BLOOM, SR .
DIGESTION, 1984, 30 (04) :255-262
[4]   Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP) [J].
Allison, David B. ;
Gadde, Kishore M. ;
Garvey, William Timothy ;
Peterson, Craig A. ;
Schwiers, Michael L. ;
Najarian, Thomas ;
Tam, Peter Y. ;
Troupin, Barbara ;
Day, Wesley W. .
OBESITY, 2012, 20 (02) :330-342
[5]  
Anderson JW, 2001, AM J CLIN NUTR, V74, P579
[6]   AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training [J].
Aponte, Yexica ;
Atasoy, Deniz ;
Sternson, Scott M. .
NATURE NEUROSCIENCE, 2011, 14 (03) :351-355
[7]   The importance of the gut microbiota after bariatric surgery [J].
Aron-Wisnewsky, Judith ;
Dore, Joel ;
Clement, Karine .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2012, 9 (10) :590-598
[8]   Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study [J].
Astrup, Arne ;
Rossner, Stephan ;
Van Gaal, Luc ;
Rissanen, Aila ;
Niskanen, Leo ;
Al Hakim, Mazin ;
Madsen, Jesper ;
Rasmussen, Mads F. ;
Lean, Michael E. J. .
LANCET, 2009, 374 (9701) :1606-1616
[9]   Central melanocortin receptor agonist reduces spontaneous and scheduled meal size but does not augment duodenal preload-induced feeding inhibition [J].
Azzara, AV ;
Sokolnicki, JP ;
Schwartz, GJ .
PHYSIOLOGY & BEHAVIOR, 2002, 77 (2-3) :411-416
[10]   The gut microbiota as an environmental factor that regulates fat storage [J].
Bäckhed, F ;
Ding, H ;
Wang, T ;
Hooper, LV ;
Koh, GY ;
Nagy, A ;
Semenkovich, CF ;
Gordon, JI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (44) :15718-15723